Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ANI Pharmaceuticals, Inc. - Common Stock (NQ:ANIP)

83.02 -1.00 (-1.19%)
Streaming Delayed Price Updated: 11:25 AM EST, Nov 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 84,819
Open 84.22
Bid (Size) 82.88 (100)
Ask (Size) 83.16 (100)
Prev. Close 84.02
Today's Range 82.50 - 85.17
52wk Range 52.50 - 99.50
Shares Outstanding 24,422,240
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
The 5 Most Interesting Analyst Questions From ANI Pharmaceuticals’s Q3 Earnings Call
ANI Pharmaceuticals delivered a third quarter marked by substantial year-over-year growth, with management attributing performance to strong momentum across its Rare Disease and Generics segments. CEO... 
Via StockStory
Topics Earnings
News headline image
Generic Pharmaceuticals Stocks Q3 Recap: Benchmarking ANI Pharmaceuticals (NASDAQ:ANIP)
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including ANI Pharmaceuticals (NASDAQ:ANIP) and its peers. 
Via StockStory
Topics Artificial Intelligence Intellectual Property

Performance

YTD
+49.7%
+49.7%
1 Month
-12.4%
-12.4%
3 Month
-7.5%
-7.5%
6 Month
+38.0%
+38.0%
1 Year
+50.3%
+50.3%

More News

Read More
News headline image
Generic Pharmaceuticals Q3 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) Simply the Best
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
6 Analysts Have This To Say About ANI Pharmaceuticals ↗
Via Benzinga
News headline image
4 Analysts Have This To Say About ANI Pharmaceuticals ↗
Via Benzinga
News headline image
The Bancorp: Building the Pulse of Digital Finance One Partnership at a Time ↗
Via The Motley Fool
News headline image
ANIP Q3 Deep Dive: Rare Disease Momentum and Generics Expansion Drive Upgraded Outlook
Via StockStory
News headline image
ANI PHARMACEUTICALS INC (NASDAQ:ANIP) Reports Record Q3 2025 Earnings, Beating Estimates ↗
Via Chartmill
News headline image
ANI Pharmaceuticals (NASDAQ:ANIP) Delivers Strong Q3 Numbers, Stock Soars
Via StockStory
News headline image
Earnings Scheduled For November 7, 2025 ↗
Via Benzinga
News headline image
Examining the Future: ANI Pharmaceuticals's Earnings Outlook ↗
Via Benzinga
News headline image
ANI Pharmaceuticals (ANIP) To Report Earnings Tomorrow: Here Is What To Expect
Via StockStory
Topics Artificial Intelligence
News headline image
3 Profitable Stocks We’re Skeptical Of
Via StockStory
News headline image
ANI Pharmaceuticals Inc (NASDAQ:ANIP) Screens as High Growth Momentum Stock Meeting Minervini Trend Template ↗
Via Chartmill
News headline image
ANI Pharmaceuticals Inc (NASDAQ:ANIP) Combines Strong Growth Momentum with Bullish Technical Setup ↗
Via Chartmill
News headline image
ANI Pharmaceuticals (ANIP): Buy, Sell, or Hold Post Q2 Earnings?
Via StockStory
Topics Stocks Supply Chain
News headline image
3 Low-Volatility Stocks We’re Skeptical Of
Via StockStory
News headline image
3 Small-Cap Stocks We Approach with Caution
Via StockStory
News headline image
ANI Pharmaceuticals Inc (NASDAQ:ANIP) Presents a High Growth Momentum and Technical Breakout Opportunity ↗
Via Chartmill
News headline image
3 Unpopular Stocks with Questionable Fundamentals
Via StockStory
News headline image
3 Russell 2000 Stocks with Questionable Fundamentals
Via StockStory
News headline image
A Look Back at Generic Pharmaceuticals Stocks’ Q2 Earnings: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Pack
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Generic Pharmaceuticals Stocks Q2 Earnings: ANI Pharmaceuticals (NASDAQ:ANIP) Best of the Bunch
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
ANI Pharmaceuticals Inc (NASDAQ:ANIP) Shows Strong Momentum and Growth, Fitting Minervini's Trend-Following Criteria ↗
Via Chartmill
News headline image
1 Mooning Stock for Long-Term Investors and 2 That Underwhelm
Via StockStory
Topics Emissions

Frequently Asked Questions

Is ANI Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, ANI Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does ANI Pharmaceuticals, Inc. - Common Stock trade on?
ANI Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ANI Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for ANI Pharmaceuticals, Inc. - Common Stock is ANIP on the Nasdaq Stock Market
What is the current price of ANI Pharmaceuticals, Inc. - Common Stock?
The current price of ANI Pharmaceuticals, Inc. - Common Stock is 83.02
When was ANI Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of ANI Pharmaceuticals, Inc. - Common Stock was at 11/17/25 11:25 AM ET
What is the market capitalization of ANI Pharmaceuticals, Inc. - Common Stock?
The market capitalization of ANI Pharmaceuticals, Inc. - Common Stock is 2.03B
How many shares of ANI Pharmaceuticals, Inc. - Common Stock are outstanding?
ANI Pharmaceuticals, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.